The releases notes that other XOS materials, produced via different processes, result in different and distinct compositions, benefits, and dosages. Claims can only be made from human clinical studies completed on a specific XOS. PreticX has over 12 published human studies, and is the only prebiotic ingredient with novel claims.
Dr. Jennifer Gu, VP of R&D for AIDP, said in the release: “AIDP is committed to investing in unique products like PreticX. Only PreticX XOS can make the desired claims, which separates this unique product from other XOS prebiotics on the market. Working with the Nutrasource team was a collaborative effort achieved by joining their regulatory expertise with our science.”